Bacainn was founded in 2017. We draw on global R&D talent within our own team (based in Concord, MA) as well as with our key collaborators at the University of Massachusetts Medical School (Worcester, MA), Hudson Institute of Medical Research (Melbourne, Australia) and University of Edinburgh (Edinburgh, UK)  


Bacainn is operated by Morningside BioPharma Advisory and is funded by Morningside Ventures 


Jason Dinges, PhD, JD
Jason Dinges, PhD, JDInterim Chief Executive Officer
Chris Murphy, PhD
Chris Murphy, PhDHead of Research & Development
Jennifer Locke
Jennifer LockeChief Operating & Business Officer
Ben Miller, PharmD
Ben Miller, PharmDHead of Clinical Research
Bharat Dixit, PhD
Bharat Dixit, PhDHead of Biopharmaceutical Development & Manufacturing
Mustafa Noor, MD, FACP
Mustafa Noor, MD, FACPChief Medical Officer
Ashely Mansell, PhD
Ashely Mansell, PhDHead of Translational Science


Beth McCormick, PhD Co-Founder, Scientific Advisor
Prof. Kev DhaliwalScientific Advisor
Prof. Adriano RossiScientific Advisor